课题基金 / 基金详情

项目摘要

项目成果

Paul Sumby的其他基金

相关文献

中文摘要
翻译
项目总结 分娩后的细菌感染,即所谓的产后感染,会导致5%到10%的发病率 全球范围内的孕妇。在大多数情况下,感染仅限于生殖道,但发生率较低。 感染扩散到血液的频率,导致危及生命的败血症,产后败血症。病原体 引起产后败血症的包括A组链球菌(GAS,化脓性链球菌),这是最常见的 造成世界范围内严重产妇产后感染和死亡的原因。获得的气体流行病学数据 过去50年的历程确定了GAS致病能力的血清型变异性。 与这一建议相关的是,M28血清型分离的气体与非随机相关的病例 产后败血症。M28血清型分离株引起产后败血症的分子基础 与其他血清型相比,更高的发病率将在这项建议中进行调查。更具体地说,目标是 这项拟议的研究的目的是确定一个基因组岛的存在是否 差异2‘(RD2)是M28型GAS引起产后败血症能力增强的关键。 RD2的序列分析与该元素水平转移到M28气体中的情况一致 B组链球菌(GBS,无乳链球菌),这是一个重要的发现,因为GBS是 正常的阴道微生物区系,也是新生儿侵袭性感染的主要原因。 具体目标1:检验RD2增强M28血清型气体分离株感染能力的假设 这两种细菌都会侵袭女性生殖道,并导致败血症。为了便于检验我们的假设,我们 最近构建的具有代表性的M28的RD2缺失突变和互补突变衍生物 隔离。亲本、突变和互补菌株将在组织培养贴壁试验中进行比较, 在使用人全血的生长试验中(作为败血症的模型),在小鼠的阴道模型中 殖民主义。 具体目标2:检验RD2元素改变核心转录本丰度的假设 染色体编码的毒力因子。五个可能的转录因子和两个可能的小分子 调控RNA在RD2中编码。测试这些假定的监管机构是否有外部目标 我们将在亲本和RD2缺失突变体之间进行转录组比较 菌株(通过RNAseq)。将在体外侵袭性模型中进行气体生长的比较 感染。RNAseq数据将通过有针对性的定量RT-PCR和Western分析进行验证。 拟议研究的完成将促进我们对菌株出现和表型的理解 一种流行的革兰氏阳性病原体的异质性。具体地说,这些数据将告知 RD2关于M28气体分离株与产后败血症的关联,从而提供了一种联系 GAS基因含量与临床观察之间的关系。
英文摘要
PROJECT SUMMARY Bacterial infections following childbirth, so-called puerperal infections, cause morbidity in 5 to 10% of all pregnant women globally. In most instances the infection is limited to the reproductive tract but at low frequency the infection spreads to the blood resulting in life-threatening sepsis, puerperal sepsis. Pathogens causing puerperal sepsis include the group A Streptococcus (GAS, S. pyogenes), which is the most common cause of severe maternal puerperal infections and death worldwide. GAS epidemiological data gained over the course of the last fifty years identifies a serotype-specific variability in the ability of GAS to cause disease. Of relevance to this proposal, serotype M28 GAS isolates are non-randomly associated with cases of puerperal sepsis. The molecular basis of why serotype M28 isolates cause puerperal sepsis at a significantly higher rate relative to those of other serotypes is to be investigated in this proposal. More specifically, the goal of the proposed research is to characterize whether the presence of a genomic island, termed `region of difference 2' (RD2), is key to the enhanced ability of serotype M28 GAS to cause puerperal sepsis. Sequence analysis of RD2 is consistent with this element being horizontally transferred into M28 GAS from group B Streptococci (GBS, S. agalactiae), an important finding given that GBS are a common constituent of the normal vaginal microflora and are also a major cause of neonatal invasive infections. Specific Aim 1: Test the hypothesis that RD2 enhances the ability of serotype M28 GAS isolates to both colonize the female reproductive tract and cause sepsis. To facilitate testing our hypothesis we recently constructed RD2 deletion mutant and complemented mutant derivatives of a representative M28 isolate. The parental, mutant, and complemented strains will be compared in tissue culture adherence assays, in growth assays using whole human blood (as a model of sepsis), and in a mouse model of vaginal colonization. Specific Aim 2: Test the hypothesis that the RD2 element alters the abundance of transcripts of core chromosomally-encoded virulence factors. Five putative transcription factors and two putative small regulatory RNAs are encoded within RD2. To test whether these putative regulators have targets outside of the RD2 region we will perform transcriptome comparisons between our parental and RD2 deletion mutant strains (via RNAseq). Comparisons will be performed following GAS growth in an ex vivo model of invasive infection. RNAseq data will be verified by targeted quantitative RT-PCR and Western analyses. Completion of the proposed research will advance our understanding of strain emergence and phenotypic heterogeneity in a prevalent Gram-positive pathogen. Specifically, the data would inform on the importance of RD2 with respect to the association of M28 GAS isolates with puerperal sepsis, and thereby provide a link between GAS gene content and clinical observations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A novel regulatory system promotes group A Streptococcus survival in human blood
  • 批准号:
    10632110
  • 项目类别:
  • 资助金额:
    $21.83万
  • 财政年份:
    2022
  • 负责人:
    Paul Sumby
  • 依托单位:
A novel regulatory system promotes group A Streptococcus survival in human blood
  • 批准号:
    10522861
  • 项目类别:
  • 资助金额:
    $18.05万
  • 财政年份:
    2022
  • 负责人:
    Paul Sumby
  • 依托单位:
Delineation of the molecular mechanisms underlying group A Streptococcus virulenc
  • 批准号:
    8648987
  • 项目类别:
  • 资助金额:
    $35.35万
  • 财政年份:
    2010
  • 负责人:
    Paul Sumby
  • 依托单位:
Delineation of the molecular mechanisms underlying group A Streptococcus virulenc